Beta Bionics Is A Medical Device Company Focused On Improving The Management Of Diabetesfounded In 2015 And Headquartered In Irvinecaliforniathe Company Aims To Simplify Diabetes Care Through Innovative Solutionsit Went Public In January 2025Trading On The Nasdaq Under The Ticker Symbolbbnxthe Company Is Known For Its Key Productsincluding The Ilet Bionic Pancreasan Automated Insulin Delivery Device For Type 1 Diabetesand The Bihormonal Iletwhich Delivers Both Insulin And Glucagon For Enhanced Glucose Controlbeta Bionics Is Also Developing A Patch Pumpan Insulin Pump That Adheres Directly To The Skinthe Company Collaborates With Partners Like Xeris Pharmaceuticals And Abbott Diabetes Care To Advance Its Technology And Offerings Led By Co Founder Ed Damiano And Ceo Sean Saintbeta Bionics Is Dedicated To Serving The Diabetes Communityfocusing On Improving The Quality Of Life For Individuals With Type 1 And Insulin Dependent Type 2 Diabetesthe Company Employs Around 294 People And Continues To Expand Its Impact In Diabetes Management
